CONFERENCES

      European Proteomics Association Annual Congress

      This is an annual conference by European Proteomics Association (EuPA) that focuses on the latest developments in proteomics research, with topics ranging from emerging technologies to data analysis. The conference is aimed at scientists, researchers, and other professionals involved in the study and application of proteomics, and provides a forum for sharing knowledge and collaborating on new approaches to proteomics research.

      7th EuPA Conference 2013

      Date

      Oct 14, 2013 - Oct 17, 2013

      Location

      St. Malo, France

      Organised by the French Proteomics Society (SFEAP) and the French Society for Mass Spectrometry (SFSM), this conference includes a study by PMI to identify regulated proteins in mouse lungs in response to cigarette smoke exposure and to determine the feasibility of such an approach in assessing the use of novel modified risk tobacco products.

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.